Fidelity Investments’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.4K | Sell |
26,323
-15,047
| -36% | -$36.3K | ﹤0.01% | 3787 |
|
|
2025
Q1 | $91.4K | Sell |
41,370
-2,088,081
| -98% | -$4.61M | ﹤0.01% | 3597 |
|
|
2024
Q4 | $11.6M | Sell |
2,129,451
-349,784
| -14% | -$1.91M | ﹤0.01% | 1890 |
|
|
2024
Q3 | $20.6M | Sell |
2,479,235
-159,159
| -6% | -$1.32M | ﹤0.01% | 1696 |
|
|
2024
Q2 | $18.9M | Buy |
2,638,394
+2,083,301
| +375% | +$14.9M | ﹤0.01% | 1674 |
|
|
2024
Q1 | $4.81M | Buy |
555,093
+97,885
| +21% | +$849K | ﹤0.01% | 2088 |
|
|
2023
Q4 | $2.99M | Buy |
457,208
+450,379
| +6,595% | +$2.95M | ﹤0.01% | 2214 |
|
|
2023
Q3 | $68.3K | Buy |
6,829
+1,237
| +22% | +$12.4K | ﹤0.01% | 3247 |
|
|
2023
Q2 | $69.5K | Sell |
5,592
-967,663
| -99% | -$12M | ﹤0.01% | 3302 |
|
|
2023
Q1 | $13.6M | Buy |
973,255
+878,476
| +927% | +$12.3M | ﹤0.01% | 1761 |
|
|
2022
Q4 | $1.36M | Sell |
94,779
-2,432,900
| -96% | -$34.8M | ﹤0.01% | 2475 |
|
|
2022
Q3 | $64.5M | Sell |
2,527,679
-1,480,224
| -37% | -$37.8M | 0.01% | 1137 |
|
|
2022
Q2 | $114M | Sell |
4,007,903
-5,432,087
| -58% | -$154M | 0.01% | 924 |
|
|
2022
Q1 | $333M | Sell |
9,439,990
-3,267,656
| -26% | -$115M | 0.03% | 584 |
|
|
2021
Q4 | $532M | Sell |
12,707,646
-5,179,650
| -29% | -$217M | 0.04% | 440 |
|
|
2021
Q3 | $878M | Buy |
17,887,296
+5,235,025
| +41% | +$257M | 0.07% | 260 |
|
|
2021
Q2 | $528M | Buy |
12,652,271
+2,949,028
| +30% | +$123M | 0.04% | 408 |
|
|
2021
Q1 | $346M | Buy |
9,703,243
+3,996,681
| +70% | +$142M | 0.03% | 568 |
|
|
2020
Q4 | $160M | Buy |
+5,706,562
| New | +$160M | 0.01% | 840 |
|